BusinessQuiet 72d · day 75
Eli Lilly to acquire Merida Biosciences for up to $2.875B
The drugmaker bolsters its immunology portfolio with a cash deal for the privately held biotech company.
What to know
- Eli Lilly is acquiring privately held Merida Biosciences for up to $2.875 billion in an all-cash transaction.
- The deal is designed to enhance Lilly's immunology portfolio capabilities.
- Multiple major financial outlets reported the announcement on August 31, 2026.
“Eli Lilly plans to buy privately held Merida Biosciences for up to $2.88 billion in cash.”
CNBC · CNBC
Eli Lilly Acquiring pharmaceutical companyMerida Biosciences Acquired biotech company
The record 13 articles and posts · last 30 days
- summary covers to here · Aug 31, 10:28 AM · 4 pieces above arrived after